Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03617419 · ClinicalTrials.gov registry record · NA
Vscan Access R2 Feasibility Evaluation
A NA study, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03617419 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 16 participants.
The verdict
NCT03617419, a NA study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study is being done to evaluate if the Vscan Access R2 Ultrasound System can measure Fetal Heart Rate (FHR) in humans when compared against a reference device (GE Corometrics 170 Series Fetal Monitor), and to gather feedback from device operators on the usability of the device.
Interventions
- DEVICE GE VScan Access R2 Ultrasound System
- DEVICE GE Corometrics 170 Series Fetal Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2017-11-14 |
| Est. Completion | 2018-02-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03617419
The ClinicalTrials.gov registry entry for NCT03617419 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which GE VScan Access R2 Ultrasound System is the first listed.
NCT03617419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03617419 about?
NCT03617419 is a clinical study titled "Vscan Access R2 Feasibility Evaluation". This study is being done to evaluate if the Vscan Access R2 Ultrasound System can measure Fetal Heart Rate (FHR) in humans when compared against a reference device (GE Corometrics 170 Series Fetal Monitor), and to gather feedback from device operators on the usability of the device.
What is the current status of trial NCT03617419?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2017-11-14. Estimated completion is 2018-02-26.
What interventions are being tested in trial NCT03617419?
The interventions under investigation include: GE VScan Access R2 Ultrasound System (DEVICE), GE Corometrics 170 Series Fetal Monitor (DEVICE).
Who is sponsoring clinical trial NCT03617419?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.